Skip to content

Jason H Sklerov

5 papers in the library · 270 citations · publishing 1999-2006

Papers

Sort Most recent Most cited

A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation.

Journal of Analytical Toxicology 2005 Jason H Sklerov, Barry Levine, Karla A. Moore et al. 142 citations

A case of a 25-year-old white male who was found dead the morning after consuming herbal extracts containing beta-carbolines and hallucinogenic tryptamines is presented. No anatomic cause of death was found at autopsy. Toxicologic analysis of the heart blood identified N,N-dimethyltryptamine (0.02 mg/L), 5-methoxy-N,N-dimethyltryptamine (1.88 mg/L), tetrahydroharmine (0.38 mg/L), harmaline...

DOI: 10.1093/jat/29.8.838 (opens in new tab) Full text (opens in new tab) Forensic toxicology Forensic analysis Toxicological investigation Drug testing +27

A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS.

Journal of Analytical Toxicology September 1, 2004 Shawn P Vorce, Jason H Sklerov 79 citations

Recent additions of designer tryptamines and phenethylamines to the Drug Enforcement Administration's schedule of controlled substances necessitate analytical procedures for their detection and quantitation. As specific immunoassays are not currently available and cross-reactivities with existing assays are unknown, a screening method based on gas chromatography-mass spectrometry was developed....

DOI: 10.1093/jat/28.6.407 (opens in new tab) Full text (opens in new tab) Designer drugs Forensic toxicology Analytical methods

Liquid Chromatography-Electrospray Ionization Mass Spectrometry for the Detection of Lysergide and a Major Metabolite, 2-Oxo-3-Hydroxy-LSD, in Urine and Blood

Journal of Analytical Toxicology October 1, 2000 Jason H Sklerov, Joseph Magluilo, K. K. Shannon et al. 30 citations

A method is presented for the quantitative measurement of lysergide (LSD) and its metabolite 2-oxo-3-hydroxy-LSD (O-H-LSD) in urine and blood. O-H-LSD has been reported to have urinary concentrations many times higher than LSD. Measuring its presence in urine would significantly extend the detection time for confirming LSD abuse. A single-step liquid-liquid extraction was performed on 5-mL...

DOI: 10.1093/jat/24.7.543 (opens in new tab) Full text (opens in new tab) Metabolite Urine Electrospray ionization Liquid chromatography–mass spectrometry

Detection of Lysergic Acid Diethylamide (LSD) in Urine by Gas Chromatography-Ion Trap Tandem Mass Spectrometry

Journal of Analytical Toxicology October 1, 1999 Jason H Sklerov, Kathryn S. Kalasinsky, C. A. Ehorn 19 citations

A confirmatory method for the detection and quantitation of lysergic acid diethylamide (LSD) is presented. The method employs gas chromatography-tandem mass spectrometry (GC-MS-MS) using an internal ionization ion trap detector for sensitive MS-MS-in-time measurements of LSD extracted from urine. Following a single-step solid-phase extraction of 5 mL of urine, underivatized LSD can be measured...

DOI: 10.1093/jat/23.6.474 (opens in new tab) Full text (opens in new tab) Lysergic acid diethylamide Urine Detection limit Tandem mass spectrometry +5